R.I. overdose deaths decline for second year in a row
Rhode Island saw its lowest number of fatal drug overdoses since 2020, according to health department data presented to the Governor's Overdose Task Force on Wednesday.
'This is a sign of hope,' Gov. Dan McKee said in a statement Wednesday. 'We know there is still much work ahead, but the steps we are taking are saving lives.'
This is the second year in a row that overdose deaths have dropped. There were 329 Rhode Islanders who died from overdoses in 2024, representing an 18.6% decrease from 2023, and a 25% drop compared to 2022. That means the state is well on its way to achieving its goal of a 30% reduction for 2030. The goal was set in 2022, the year a total of 436 people died of drug overdoses.
The 2024 data demonstrated another longstanding trend now broken: For the first time since 2013, cocaine-related deaths were implicated in 61% of fatal overdoses, surpassing the 57% of deaths associated with fentanyl.
All opioid-related overdoses, in fact, fell from 85% the previous year to 69% in 2024.
But more than one substance can contribute to an overdose, so distinguishing the role of cocaine or fentanyl in a death is not so neatly accomplished. A large portion of overdoses — 118 in all — involved both substances being used in tandem in 2024. About three in five people who died from cocaine also had fentanyl in their system.
The annual overdose data is compiled and interpreted by the Rhode Island Department of Health's (RIDOH) Substance Use Epidemiology Program, which finished reviewing the 2024 results last week, according to Joseph Wendelken, a department spokesperson.
The data is largely based on autopsy and toxicology findings from the Office of the State Medical Examiners. Personal medical history also informs the coroners' findings. The data does not include deaths with undetermined causes.
'Though decline is encouraging, this is still an incredible loss in our community,' Heidi Weidele, the health department's lead fatal overdose epidemiologist, told the task force Wednesday during her presentation on the data.
The scale of loss did not affect all people equally: 70% of overdose deaths in 2024 were men, a number consistent with recent years. Similarly, people ages 45 to 54 were the largest age-based cohort of overdose deaths, followed by people ages 55 to 64.
By race, non-Hispanic white Rhode Islanders comprised the largest share of overdoses at 73%, even though they were also most likely to have a history of substance use treatment.
Most of the state's overdoses were concentrated in urban areas, with Woonsocket, Providence and Pawtucket reporting the highest numbers.
Though decline is encouraging, this is still an incredible loss in our community.
– Heidi Weidele, lead fatal overdose epidemiologist, Rhode Island Department of Health
Weidele said the deceased most commonly worked in 'natural resources, construction, maintenance, and service occupations, which is similar to what we've seen in past years,' she told the task force. 'And service occupations would be things like health care support, law enforcement, food preparation, grounds maintenance, and personal care.'
Other statistics from the report painted a grim picture of the deceased leading up to final moments: Most never sought substance use treatment, or received medical treatment for a previous overdose.
Eight out of 10 died in private, in a home, garage or camper. Most overdosed alone, with no bystander present in 60% of cases.
The availability of lethal drugs has also influenced overdose trends over the years. In 2009, prescription drugs accounted for 62% of overdose deaths. By 2020, prescription drugs accounted for only 9% of fatal overdoses, while illicit drugs like fentanyl and cocaine comprised 72% of overdose deaths.
In 2024, the state actually saw 34% of deaths attributed to combinations of illicit and prescription drugs combined — the highest percentage since at least 2009.
A few uncommon culprits in overdose deaths were still marked as 'substances of concern' by the state health department. These included novel benzodiazepines, tranquilizers which belong to the much broader category of research chemicals — substances derived from or chemically very similar to legal and regulated drugs. In this case, novel benzodiazepines like clonazolam — about two-and-a-half-times stronger than Xanax — accounted for nine fatalities in 2024.
Brown University researcher: Street drugs are getting more potent and more mysterious
Xylazine, a veterinary anesthetic increasingly being used to cut street-sourced opioids, was another rogue substance that continued to impact overdose data in 2024. It was involved in 37% of opioid-related deaths.
'Every single overdose death is preventable,' Health Department Director Dr. Jerry Larkin said in a statement Wednesday. 'Recovery is within reach for every person living with the disease of addiction.'
McKee strengthened the Overdose Task Force — a coalition of more than 150 members divvied up into nine workgroups — in 2022 via an executive order, hoping to ensure a sustained state response to the opioid overdose crisis. Among the initiatives it steers are determining how to dispense opioid settlement funds, naloxone distribution networks, peer outreach, and recovery support and public awareness campaigns.
Earlier this year, Rhode Island also opened the nation's first state-regulated harm reduction site at Project Weber/RENEW in south Providence, where people can use drugs and receive medical attention in the event of an overdose. Despite a fierce floor debate in the Rhode Island House of Representatives, legislation to extend the injection site's pilot authorization was extended by the General Assembly and later signed into law by McKee on June 6.
SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
34 minutes ago
- Yahoo
Two Young Men Die from Street Drug That's 43 Times Stronger than Fentanyl. It's Taking Hold in the U.S.
Experts are warning about nitazenes — synthetic opioids with different, deadly strains — that can be hidden in other drugsNEED TO KNOW A synthetic opioid that's 43 times stronger than fentanyl and 250 times stronger than heroin has caused hundreds of deaths in the U.K., and has now spread to the U.S. Nitazenes are behind the deaths of two young men in Texas, who took pills that were laced with the potent drug Their mothers are speaking out to raise awareness and warn others about the deadly substanceExperts are warning about a dangerous drug hitting the streets that's up to 43 times stronger than fentanyl and 250 times stronger than heroin — that's already killed two young men in Texas. Nitazenes are synthetic opioids that are produced in China and, like fentanyl, can be found mixed in drugs like heroin and pills. The Wall Street Journal reports the drug is so potent, even trace amounts can be fatal — and it's already caused at least 400 deaths in the U.K. But now the drug is stateside: The families of two young Texas men who died from taking pills laced with the drugs are speaking out. In January, Lucci Reyes-McCallister, 22, died near Houston after taking a pill that he thought was Xanax, his mother, Grey McCallister, told the New York Post, explaining that her son's pill was laced with a form of nitazene. Three months later, in April, a friend of Lucci's, 21-year-old Hunter Clement, died after taking what he believed to be a Percocet. His mother, Ruthi Clement, told the Post she found her son face-down in his bed, his skin purple. Two doses of Narcan didn't work to revive her son. Narcan — the branded name for naloxone — is an emergency medication intended to reverse the effects of a narcotic overdose. But nitazenes are so potent that Narcan isn't as effective as it is against a heroin overdose, for example. The reason for the influx of fentanyl, and now nitazenes, is that it's easier to smuggle in smaller, but more potent drugs, U.K. National Crime Agency Deputy Director Charles Yates told the WSJ. 'They buy potent nitazenes cheaply and mix them with bulking agents such as caffeine and paracetamol to strengthen the product being sold and make significant profits,' Yates told the outlet. Although it's commonly mixed into pills and powders, a man in Sydney was arrested on Aug. 5 for selling vapes that were "supercharged" with the drug, The Guardian reports. There are 17 different strains circulating in the U.S., the Drug Enforcement Agency reports in the 2025 National Drug Threat Assessment. The drug is so new that it's not part of routine testing, the WSJ says, but research from 2022 found 93 deaths that were attributable to strains of nitazenes. N-pyrrolidino etonitazenes are the most potent, up to 43 times stronger than fentanyl, the Inter-American Drug Abuse Control Commission says. N-pyrrolidino protonitazenes — the type that killed Lucci — is 25 times the strength of fentanyl. Lucci's death, his mother told the Post, 'was the first time I'd ever heard of [nitazene].' Hunter's mother shared that she's speaking out because, 'Sometimes I get mad because I couldn't save my own son. I do want to save other people, even if it's just one person in honor of him.' Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories. Read the original article on People Solve the daily Crossword
New York Post
2 hours ago
- New York Post
Parents pack survival kits for college-bound kids — Narcan, Plan B included
Pencils, notebooks — and Narcan? Concerned parents of incoming college freshmen are adding the life-saving nasal spray to back-to-school lists this year — along with condoms, Plan B and more modern must-haves that might have been unthinkable a generation ago. And that's just fine with students like Summer, 20, who said they prefer a matter-of-fact approach to the way campus life is lived now. Advertisement 8 Narcan, an opioid antagonist, is rising as a top back-to-school necessity for college kids heading to campus in the fall. Getty Images 'I administered Narcan to a girl who was passed out on the front lawn of an off-campus frat party,' the psych major from North Carolina, who didn't want to use her last name, told The Post. 'It literally saves lives.' Narcan, officially known as Naloxone, is an opioid antagonist that reverses the effects of illicit substances, such as fentanyl. Advertisement It's a serious topic of discussion among older folks with chickadees poised to leave the nest. From Facebook mom groups to viral TikTok clips, 'college survival kits' with the miracle medication are all the rage — along with contraception pills and other grown-up adds. 8 Sophia Green and her mom, Jamie, went viral after revealing the Narcan and Plan B pills packed in the teen's college survival kit. Courtesy Jamie Green Idaho mom Jamie, 42, and daughter Sophia Green, 18, recently made a big splash with a social media reveal of their list of nontraditional necessities for Sophia's first day of classes at Boise State University this fall. Advertisement And while the 5.6 million viewers of their clip were largely supportive, digital detractors downed the trend, arguing that plying adolescents with the preventative products is 'sad' and 'embarrassing.' One contrarian commenter even wrote, 'Damn, teach your daughters common sense, resilience and willpower.' Protesters of the ultra-progressive shift may rush to shame so-called 'helicopter parents' for inadvertently giving teens the green light to experiment. Advertisement But Yamalis Diaz, an adolescent psychologist at NYU Langone Health, said cautious adults are neither overstepping boundaries with their kids — nor granting them permission to party. Instead, they're simply preparing the pups for real-world eventualities. 8 Narcan is commonly administered through the nose and counteracts the effects of an opioid overdose. Dennis A. Clark 'Millennials and Gen Xers, who grew up in a very flexible, open-minded time, are now sending their Gen Z children off to college fully equipped to handle difficult situations,' Diaz told The Post. 'If parents choose to get Narcan or condoms for their kids, the message isn't, 'Here, go do drugs and have sex,' ' she insisted. 'The message is, 'I don't want you to get into any kind of tricky predicaments, but here are some tools that you can use to make smart choices after the fact.' ' It's a message that youngsters need now more than ever, statistics show. An alarming 50,000 teenagers confessed to misusing fentanyl, a synthetic opioid, in 2023, per a recent report from the Substance Abuse and Mental Health Services Administration, a branch of the Department of Health and Human Services. Researchers discovered a 47% spike in teen fentanyl use from 2022 to 2023. They attributed the startling uptick to the fact that many youngsters could have taken it without realizing. Advertisement Representatives for the Drug Enforcement Administration have deemed fentanyl, a Schedule I drug, the 'leading cause of death for adults ages 18 to 45 in the US,' according to the DEA's Campus Drug Prevention site. Summer's distressed schoolmate could have ended up just another statistic — but luckily, the quick thinker had taken an on-campus harm reduction seminar and knew what to do. 'She was super pale, her breathing was shallow and her pupils were pinpoint, which is a sign of overdose,' she recalled. Advertisement Now, she's always prepared with a supply of the medication, which is available as an over-the-counter commodity at most nationwide drugstores and online outlets like Amazon, where it costs around $45. 'I always keep Narcan in my purse when I go to college events, parties and festivals — because you just never know,' she said. 'Better to be safe than sorry.' 8 Gretchen is proudly giving her daughter all of the tools she needs to navigate difficult situations during the upcoming semester. Courtesy Gretchen Schaefer Maine mama Gretchen Schaefer, 50, who's sending her daughter, Ingrid, 19, back to school with a stash of Narcan and Plan B, agrees. Advertisement In fact, the mother of two said she's encouraging others with college kiddos to follow suit. 'The most common objection I hear is, 'Well, my kid doesn't hang out with drug users,' ' said Schaefer, noting that Ingrid kicks it with the sober crowd at her school in Massachusetts. 'But what if someone was slipped something and they have to reverse an overdose?' @snappity207 I made my kid a health kit for college instead of buying a prepackaged first aid kit. She may not need a few of these things, but knows to share if someone does and I will happily resupply. #college #dormhaul #firstaid #backtoschool ♬ original sound – Gretchen's Kitchen The vigilant mom is also keen on reversing the effects of unprotected sex. Advertisement 'In the case of sexual assault, I want her or someone on her dorm floor to have the Plan B on hand,' she added. 'It was $6 at Costco.' To ensure that Ingrid knows how and when to use all of the remedies in her 'health kit,' Schaefer's even created, printed and laminated an emoji-coded list of detailed instructions. Schaefer's medicine how-to prompts include, 'Can't poop? Take 2 SennaLax before bed,' and 'Oops, condom broke? Take 1 Plan B ASAP after unprotected sex (within 72 hours).' 8 As an extra precaution, Schaefer curated a detailed list of all the medical emergency items, their uses and recommended dosages in Ingrid's college health kit. Courtesy Gretchen Schaefer 8 Schaefer tells The Post that she purchased the Narcan, Plan B contraceptive pills and other emergency health supplies for Ingrid because there aren't many pharmacies near the teen's school. Getty Images She's not being overprotective; she's simply passing the torch. 'I'm the Swiss Army knife mom,' said Schaefer. 'I want her to be the Swiss Army knife roommate.' Jamie Green wants her Sophia to gain a similar reputation around the dorms. 8 Jamie says her family openly discusses drug and sex safety practices. Courtesy Jamie Green. 'It super important to be prepared,' Jamie, a social worker who's also at Boise State pursuing a master's degree, told The Post. She hopes Sophia's new crop of college friends feels comfortable turning to her for support when necessary. 'The Narcan and Plan B aren't necessarily for Sophia, but they're for anyone on campus in need,' said Jamie. 'They can confidentially come to her and get help.' 8 Sophia dreams of becoming a doctor who specializes in women's health and care. Courtesy Jamie Green Sophia, an aspiring OB/GYN, looks forward to being a safe haven over the next four years. 'My mom and I have always had a very open relationship, and it feels really great that she's setting me up for success in case of any emergencies because s–t happens,' said Sophia. 'It's better to be prepared than keeping secrets, lying and maybe ending up in a worse situation. 'I'm glad other girls in my dorm will be able to trust me or my mom if they don't have anyone else.'
Yahoo
4 hours ago
- Yahoo
Boehringer's Hernexeos receives fast-tracked FDA approval
Boehringer Ingelheim has received fast-track approval from the US Food and Drug Administration (FDA) for its targeted therapy, Hernexeos (zongertinib tablets), to treat non-small cell lung cancer (NSCLC). This approval succeeds the positive results of the Phase Ib Beamion-LUNG 1 trial (NCT04886804), with the oral tyrosine kinase inhibitor (TKI) demonstrating an objective response rate (ORR) of 75% in patients with HER2-positive NSCLC who had received prior lines of platinum-based chemotherapy. Its FDA approval makes it the first oral treatment for HER2-positive NSCLC. Hernexeos also triggered a duration of response (DOR) of more than six months in 58% of the 71 patients previously treated with chemotherapy alone, while 27% of the 34 individuals with prior exposure to chemotherapy and a HER2 targeted therapy experienced a DOR of this length. Impacting 2%-4% of patients diagnosed with NSCLC, HER2 mutations are associated with poor prognosis and a higher risk of brain metastasis, while treatment options are highly limited in this population. Due to Hernexeos' potential to fulfil unmet needs in this indication, the FDA granted Boehringer priority review and breakthrough therapy designation last year. The therapy's full approval will likely rely on verification of clinical benefit in a confirmatory trial. Dr John Heymach, co-ordinating investigator on the Beamion-LUNG 1 trial and chair of thoracic/head and neck medical oncology at the MD Anderson Cancer Centre, said: 'The approval of zongertinib offers an effective and targeted treatment option for patients with HER2-mutant NSCLC in the US that not only elicits a durable response, but also has a manageable safety profile. 'In a patient population where there are currently limited treatment options, this approval represents a significant advancement in cancer care.' HER2-targeted therapy race heats up Though the current standard of care (SoC) for patients with HER2-mutated NSCLC still revolves around a platinum-based chemotherapy regimen, physicians are increasingly prescribing targeted therapies to improve outcomes. A notable example of this is AstraZeneca and Daiichi Sankyo's antibody-drug conjugate (ADC) Enhertu (trastuzumab deruxtecan), which became the first HER2-targeting therapy to receive approval for NSCLC in 2022. Following its accelerated FDA approval, the drug has already reached blockbuster status – raking in $4.1bn in 2024 for the company, according to Pharmaceutical Technology's parent company, GlobalData. GlobalData predicts that the drug is on track to pull in $14.6bn by 2031, highlighting the lucrative nature of the targeted oncology market. However, Hernexeos has demonstrated a higher ORR of 75% compared with Enhertu's 56% in the DESTINY-Lung02 trial. The TKI has also proved efficacious in patients who had previously received treatment with an ADC, suggesting that the TKI could absorb some of Enhertu's market share. Looking ahead, the drug may also face competition from other targeted therapies currently in Phase III clinical trials, with GlobalData giving Bayer's TKI sevabertinib a likelihood of approval (LoA) score of 81% in this indication. "Boehringer's Hernexeos receives fast-tracked FDA approval" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
